Syndax Pharmaceuticals Inc (SNDX) — Cash Flow Reinvestment Rate
Syndax Pharmaceuticals Inc (SNDX) has a Cash Flow Reinvestment Rate of 0.60x as of December 2021, reinvesting $59.96 Million (capex $129.00K plus investments $-59.83 Million) from operating cash flow of $100.71 Million. Explore Syndax Pharmaceuticals Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Syndax Pharmaceuticals Inc Cash Flow Reinvestment Rate (2021–2021)
Historical reinvestment intensity for Syndax Pharmaceuticals Inc across 1 annual periods. Also explore Syndax Pharmaceuticals Inc balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Syndax Pharmaceuticals Inc (2021–2021)
Year-by-year capital reinvestment analysis for Syndax Pharmaceuticals Inc. For live market cap and broader valuation context, see SNDX market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 1.40x | $40.87 Million | $29.13 Million | $129.00K | — |